The US Institute for Safe Medication Practices considers insulin to be one of the top 5 ‘high-alert’ medications i.e. drugs that bear a heightened risk of causing significant patient harm when they are used in error.
Recent Posts
- Safe use of Oxytocin 17 June 2024
- IMSN Medication Safety Bulletin & other published material 13 May 2024
- Speech by Minister Simon Coveney to the IMSN conference in UCC on 24th November 2023 24 November 2023
- Building a Medication Safety Programme in a Hospital in Ireland: Fundamental Steps 5 July 2023
- Lithium-Prescribing & Monitoring (Best Practice Guidelines and Patient Information) 8 September 2022